# Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/therapeutic-strategies-to-overcome-crizotinib-resistance-in-non-small-cell-lung/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ryohei Katayama,Tahsin M. Khan,Cyril H. Benes,Eugene Lifshits,Hiromichi Ebi,Victor M. Rivera,William C. Shakespeare,A. John Iafrate,Jeffrey A. Engelman,Alice T. Shaw |
| Citations | 542 |
| DOI | 10.1073/pnas.1019559108 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | http://hdl.handle.net/1721.1/67357 |
| OpenAlex ID | https://openalex.org/W2170144893 |
| PMID | 21502504 |
| Type | article |
| Year | 2011 |

## Paper authors

- [A. John Iafrate](https://scholariq.org/researchers/a-john-iafrate/)
- [Jeffrey A. Engelman](https://scholariq.org/researchers/jeffrey-a-engelman/)
- [Hiromichi Ebi](https://scholariq.org/researchers/hiromichi-ebi/)
- [Alice T. Shaw](https://scholariq.org/researchers/alice-t-shaw/)

## Paper journal

- [Proceedings of the National Academy of Sciences](https://scholariq.org/journals/proceedings-of-the-national-academy-of-sciences/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.